| Document Date: 2003-07-21 14:51:58
Open Document File Size: 219,83 KBShare Result on Facebook
City Neuroreport / Berlin / London / Sunderland / New York / / Company Sinauer Associates / Oxford University Press / PCP / LSD / / Country United States / Mexico / / Facility plant Mimosa / / IndustryTerm serotonergic and dopaminergic systems / structure groups / metabolic imaging studies / / MedicalCondition hallucination / chronic state / tremors / DF / organic psychoses / subacute and chronic schizophrenics / schizophrenia / disease / true hallucinations / schizophrenic syndrome / hallucinations / acute syndrome / Psychiatric Disorders / psychoses / drug abuse / mental illness / endogenous psychoses / thought disorder / dizziness / depression / chronic schizophrenics / chronic course / syndrome / mental disorders / / MedicalTreatment imagery / / Organization Oxford University / / Person Paul Aron / Davis MacGibbon / Timothy Leary / Davis M. Mescaline / Albert Hofmann / Kay SR. / / Position Prime Minister / General / / ProvinceOrState Massachusetts / / PublishedMedium Archives of General Psychiatry / Journal of Neuroscience / Journal of Psychoactive Drugs / / Region southwestern United States / / Technology Neuroscience / tomography / /
SocialTag |
Hallucinogens and Schizophrenia Use of the term ‘hallucinogen’ immediately calls into question the precise meaning of the word. Literally, it means ‘a substance that induces hallucinations’, where ‘hallucination’ is defined as